Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1995-03-24
1997-06-10
McKane, Joseph
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
540557, A61K 3155, C07D49504, C07D24310
Patent
active
056375840
ABSTRACT:
The invention provides a methylene chloride solvate of 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine. The invention provides a method for using such solvate.
REFERENCES:
patent: 3951981 (1976-04-01), Safir et al.
patent: 4115568 (1978-09-01), Chakrabarti et al.
patent: 4337198 (1982-06-01), Sorg et al.
patent: 4542131 (1985-09-01), Chakrabarti et al.
patent: 5229382 (1993-07-01), Chakrabarti et al.
patent: 5457101 (1995-10-01), Greenwood et al.
patent: 5561127 (1995-10-01), Tehim et al.
Boone David E.
Eli Lilly and Company
Lilly Industries Limited
McKane Joseph
Myers, Jr. Richard S.
LandOfFree
Solvate of olanzapine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Solvate of olanzapine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Solvate of olanzapine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-764801